content: <HTML><HEAD>
  <TITLE>Form 8-K</TITLE>
  </HEAD>
    <BODY BGCOLOR="WHITE">
  
   <HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left"><DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="5" COLOR="#000000"><B>SECURITIES AND EXCHANGE COMMISSION
  </B></FONT></DIV> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Washington, D.C. 20549 </B></FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV ALIGN="center"><FONT
  FACE="Times New Roman" SIZE="5" COLOR="#000000"><B>FORM 8-K </B></FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="3" COLOR="#000000"><B>CURRENT REPORT </B></FONT></DIV> <DIV
  ALIGN="center"><FONT FACE="Times New Roman" SIZE="3" COLOR="#000000"><B>Pursuant to Section 13 or 15(d) of </B></FONT></DIV> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="3" COLOR="#000000"><B>the Securities Exchange Act of 1934
  </B></FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>October 29, 2002 </B></FONT></DIV> <HR SIZE="1" NOSHADE WIDTH="48%"
  COLOR="#000000"><DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Date of Report (date of earliest event reported) </B></FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV
  ALIGN="center"><FONT FACE="Times New Roman" SIZE="5" COLOR="#000000"><B>NPS PHARMACEUTICALS, INC. </B></FONT></DIV> <HR SIZE="1" NOSHADE COLOR="#000000"><DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>(Exact name of
  Registrant as specified in its charter) </B></FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV ALIGN="center">
  <TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">
  
  <TR>
  <TD VALIGN="bottom" WIDTH="31%" ALIGN="center"> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Delaware</B></FONT></DIV> <HR SIZE="1" NOSHADE COLOR="#000000"></TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="31%" ALIGN="center"> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>0-23272</B></FONT></DIV> <HR SIZE="1" NOSHADE COLOR="#000000"></TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="31%" ALIGN="center"> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>87-0439579</B></FONT></DIV> <HR SIZE="1" NOSHADE COLOR="#000000"></TD> </TR>
  <TR>
  <TD VALIGN="top" ALIGN="center" WIDTH="31%"> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>(State or other jurisdiction of</B></FONT></DIV> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"
  COLOR="#000000"><B>incorporation or organization)</B></FONT></DIV> </TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="top" ALIGN="center" WIDTH="31%"> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>(Commission File Number)</B></FONT></DIV> </TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="top" ALIGN="center" WIDTH="31%"> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>(I.R.S. Employer</B></FONT></DIV> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Identification
  Number)</B></FONT></DIV> </TD> </TR>
   </TABLE> </DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>420 Chipeta Way
  </B></FONT></DIV> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Salt Lake City, Utah 84108-1256 </B></FONT></DIV> <HR SIZE="1" NOSHADE WIDTH="48%" COLOR="#000000"><DIV ALIGN="center"><FONT FACE="Times New Roman"
  SIZE="1" COLOR="#000000"><B>(Address of principal executive offices) </B></FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>(801)
  583-4939 </B></FONT></DIV> <HR SIZE="1" NOSHADE WIDTH="48%" COLOR="#000000"><DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>(Registrant&#146;s telephone number, including area code) </B></FONT></DIV> <DIV><FONT
  SIZE="1">&nbsp;</FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left">
  
  <p Style='page-break-before:always'>
  <HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
  
   <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV STYLE="text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">This Current Report on Form 8-K is filed by NPS Pharmaceuticals, Inc., a Delaware
  corporation (the &#147;<B><I>Registrant</I></B>&#148;), in connection with the matters described herein. </FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ITEM
  5:&nbsp;&nbsp;&nbsp;&nbsp;OTHER EVENTS. </B></FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV STYLE="text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">On October 25, 2002, the Registrant announced that it has priced its
  public offering (the &#147;Offering&#148;) of 4,000,000 shares of its common stock, par value $0.001 per share, at a price of $23.95 per share. The Registrant offered all of the 4,000,000 shares pursuant to its shelf Registration Statement on Form
  S-3 (File No. 333-76532) (the &#147;Registration Statement&#148;) declared effective by the Securities and Exchange Commission on March 25, 2002. The underwriters have a 30-day option to purchase up to 600,000 additional shares of common stock from
  the Registrant solely to cover over-allotments, if any. </FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV STYLE="text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The managing underwriters for the offering are Morgan
  Stanley &amp; Co. Incorporated. Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated and Salomon Smith Barney Inc. are acting as co-managers. </FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV STYLE="text-indent:4%"><FONT
  FACE="Times New Roman" SIZE="2" COLOR="#000000">Copies of the final Prospectus Supplement relating to the offering may be obtained from Morgan Stanley &amp; Co., Prospectus Department, 1585 Broadway, New York, NY 10036 (212-761-6775). </FONT></DIV>
  <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV STYLE="text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">This announcement is neither an offer to sell nor a solicitation of an offer to buy, nor shall there be any sale of these
  securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state. A registration statement relating to these securities has been filed with and has
  been declared effective by the Securities and Exchange Commission. </FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV STYLE="text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Attached hereto as <U>Exhibit 1.1</U>, and
  incorporated herein by this reference, is a copy of the Underwriting Agreement, dated as of October 24, 2002, by and among the Registrant and Morgan Stanley &amp; Co. Incorporated, Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, and Salomon
  Smith Barney Inc., acting as representatives of the several underwriters of the Offering. Attached as <U>Exhibit 5.1</U>, and incorporated herein by this reference, is the opinion of Wilson Sonsini Goodrich &amp; Rosati, Professional Corporation
  relating to the legality of the shares of common stock to be offered by the Registrant in the Offering. Attached as <U>Exhibit 99.1</U>, and incorporated herein by this reference, are the sections of the Prospectus Supplement dated October 24, 2002,
  to the Registration Statement on Form S-3 (File No. 333-76532) entitled &#147;Risk Factors,&#148; &#147;Business,&#148; and &#147;Management.&#148; </FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV><FONT FACE="Times New Roman" SIZE="2"
  COLOR="#000000"><B>ITEM 7:&nbsp;&nbsp;&nbsp;&nbsp;FINANCIAL STATEMENTS AND EXHIBITS. </B></FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
  <TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
  <TR>
  <TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
  <TD WIDTH="3%" VALIGN="top" ALIGN="left"><DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)</FONT></DIV></TD>
  <TD WIDTH="1%" VALIGN="top"><DIV><FONT SIZE="1">&nbsp;</FONT></DIV></TD>
  <TD ALIGN="left" VALIGN="top"><DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><U>Financial Statements of Business Acquired</U>. </FONT></DIV> </TD></TR></TABLE> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV
  STYLE="margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Not applicable. </FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
  <TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
  <TR>
  <TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
  <TD WIDTH="3%" VALIGN="top" ALIGN="left"><DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)</FONT></DIV></TD>
  <TD WIDTH="1%" VALIGN="top"><DIV><FONT SIZE="1">&nbsp;</FONT></DIV></TD>
  <TD ALIGN="left" VALIGN="top"><DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><U>Pro Forma Financial Information</U>. </FONT></DIV> </TD></TR></TABLE> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV
  STYLE="margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Not applicable. </FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
  <TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
  <TR>
  <TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
  <TD WIDTH="3%" VALIGN="top" ALIGN="left"><DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)</FONT></DIV></TD>
  <TD WIDTH="1%" VALIGN="top"><DIV><FONT SIZE="1">&nbsp;</FONT></DIV></TD>
  <TD ALIGN="left" VALIGN="top"><DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Exhibits. </FONT></DIV> </TD></TR></TABLE> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV STYLE="margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman"
  SIZE="2" COLOR="#000000">The following exhibits are filed herewith: </FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV ALIGN="right">
  <TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="90%" BORDER="0">
  
  <TR>
  <TD VALIGN="top" WIDTH="5%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;1.1</FONT></DIV> </TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="87%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Underwriting Agreement dated as of October 24, 2002, by and among the Registrant and Morgan Stanley &amp; Co. Incorporated, Merrill Lynch, Pierce, Fenner
  &amp; Smith Incorporated, and Salomon Smith Barney Inc., acting as representatives of the several underwriters named in Schedule I thereto.</FONT></DIV> </TD> </TR>
  <TR>
  <TD HEIGHT="8"> </TD> </TR>
  <TR>
  <TD VALIGN="top" WIDTH="5%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;5.1</FONT></DIV> </TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="87%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Opinion of Wilson Sonsini Goodrich &amp; Rosati, Professional Corporation.</FONT></DIV> </TD> </TR>
  <TR>
  <TD HEIGHT="8"> </TD> </TR>
  <TR>
  <TD VALIGN="top" WIDTH="5%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23.1</FONT></DIV> </TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="87%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Consent of Wilson Sonsini Goodrich &amp; Rosati, Professional Corporation (included in Exhibit 5.1).</FONT></DIV> </TD> </TR>
  <TR>
  <TD HEIGHT="8"> </TD> </TR>
  <TR>
  <TD VALIGN="top" WIDTH="5%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">99.1</FONT></DIV> </TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="87%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Selected portions of the Registrant&#146;s Prospectus Supplement dated October 24, 2002, to the Registration Statement on Form S-3 (File No.
  333-76532).</FONT></DIV> </TD> </TR>
   </TABLE> </DIV>
  
  <p Style='page-break-before:always'>
  <HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
  
   <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>SIGNATURES </B></FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV
  STYLE="text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
  authorized. </FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Date:&nbsp;&nbsp;October 28, 2002 </FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV>
  <TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">
  
  <TR>
  <TD COLSPAN="3"> <FONT SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
  <TD> <FONT SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="top" COLSPAN="3" WIDTH="44%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>NPS PHARMACEUTICALS, INC.</B></FONT></DIV> </TD> </TR>
  <TR>
  <TD HEIGHT="16"> </TD> </TR>
  <TR>
  <TD> <FONT SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
  <TD> <FONT SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
  <TD> <FONT SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="top" WIDTH="2%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">By:</FONT></DIV> </TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="top" WIDTH="44%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">/s/&nbsp;&nbsp;&nbsp;&nbsp;James U. Jensen</FONT></DIV> <HR SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD> </TR>
  <TR>
  <TD> <FONT SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
  <TD> <FONT SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
  <TD> <FONT SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
  <TD> <FONT SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="44%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">James U. Jensen</FONT></DIV> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Vice President, General Counsel and Secretary</FONT></DIV> </TD>
  </TR>
   </TABLE> </DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
  
  <p Style='page-break-before:always'>
  <HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
  
   <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>EXHIBIT INDEX </B></FONT></DIV> <DIV><FONT SIZE="1">&nbsp;</FONT></DIV> <DIV
  ALIGN="center">
  <TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">
  
  <TR>
  <TD VALIGN="bottom" ALIGN="center"> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Exhibit Number</B></FONT></DIV> <HR SIZE="1" NOSHADE WIDTH="44" COLOR="#000000"></TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="92%" ALIGN="center"> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Description</B></FONT></DIV> <HR SIZE="1" NOSHADE COLOR="#000000"></TD> </TR>
  <TR>
  <TD VALIGN="top" ALIGN="center" WIDTH="7%"> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;1.1</FONT></DIV> </TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="92%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Underwriting Agreement dated as of October 24, 2002, by and among the Registrant and Morgan Stanley &amp; Co. Incorporated, Merrill Lynch, Pierce, Fenner
  &amp; Smith Incorporated, and Salomon Smith Barney Inc., acting as representatives of the several underwriters named in Schedule I thereto.</FONT></DIV> </TD> </TR>
  <TR>
  <TD HEIGHT="8"> </TD> </TR>
  <TR>
  <TD VALIGN="top" ALIGN="center" WIDTH="7%"> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;5.1</FONT></DIV> </TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="92%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Opinion of Wilson Sonsini Goodrich &amp; Rosati, Professional Corporation.</FONT></DIV> </TD> </TR>
  <TR>
  <TD HEIGHT="8"> </TD> </TR>
  <TR>
  <TD VALIGN="top" ALIGN="center" WIDTH="7%"> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;23.1</FONT></DIV> </TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="92%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Consent of Wilson Sonsini Goodrich &amp; Rosati, Professional Corporation (included in Exhibit 5.1).</FONT></DIV> </TD> </TR>
  <TR>
  <TD HEIGHT="8"> </TD> </TR>
  <TR>
  <TD VALIGN="top" ALIGN="center" WIDTH="7%"> <DIV ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">99.1</FONT></DIV> </TD>
  <TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
  <TD VALIGN="bottom" WIDTH="92%"> <DIV><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Selected portions of the Registrant&#146;s Prospectus Supplement dated October 24, 2002, to the Registration Statement on Form S-3 (File No.
  333-76532).</FONT></DIV> </TD> </TR>
   </TABLE> </DIV>
   </BODY></HTML>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "d8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 18861}]
metadata_filer: {"company-data": {"conformed-name": "NPS PHARMACEUTICALS INC", "cik": "0000890465", "assigned-sic": "2836", "irs-number": "870439579", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-23272", "film-number": "02800606"}, "business-address": {"street1": "420 CHIPETA WAY STE 240", "city": "SALT LAKE CITY", "state": "UT", "zip": "84108-1256", "phone": "8015834939"}}
text: Form 8-K
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d) of
  the Securities Exchange Act of 1934
  October 29, 2002
  Date of Report (date of earliest event reported)
  NPS PHARMACEUTICALS, INC.
  (Exact name of
  Registrant as specified in its charter)
  Delaware
  0-23272
  87-0439579
  (State or other jurisdiction of
  incorporation or organization)
  (Commission File Number)
  (I.R.S. Employer
  Identification
  Number)
  420 Chipeta Way
  Salt Lake City, Utah 84108-1256
  (Address of principal executive offices)
  (801)
  583-4939
  (Registrant's telephone number, including area code)
  This Current Report on Form 8-K is filed by NPS Pharmaceuticals, Inc., a Delaware
  corporation (the "
  Registrant
  "), in connection with the matters described herein.
  ITEM
  5:    OTHER EVENTS.
  On October 25, 2002, the Registrant announced that it has priced its
  public offering (the "Offering") of 4,000,000 shares of its common stock, par value $0.001 per share, at a price of $23.95 per share. The Registrant offered all of the 4,000,000 shares pursuant to its shelf Registration Statement on Form
  S-3 (File No. 333-76532) (the "Registration Statement") declared effective by the Securities and Exchange Commission on March 25, 2002. The underwriters have a 30-day option to purchase up to 600,000 additional shares of common stock from
  the Registrant solely to cover over-allotments, if any.
  The managing underwriters for the offering are Morgan
  Stanley & Co. Incorporated. Merrill Lynch, Pierce, Fenner & Smith Incorporated and Salomon Smith Barney Inc. are acting as co-managers.
  Copies of the final Prospectus Supplement relating to the offering may be obtained from Morgan Stanley & Co., Prospectus Department, 1585 Broadway, New York, NY 10036 (212-761-6775).
  This announcement is neither an offer to sell nor a solicitation of an offer to buy, nor shall there be any sale of these
  securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state. A registration statement relating to these securities has been filed with and has
  been declared effective by the Securities and Exchange Commission.
  Attached hereto as
  Exhibit 1.1
  , and
  incorporated herein by this reference, is a copy of the Underwriting Agreement, dated as of October 24, 2002, by and among the Registrant and Morgan Stanley & Co. Incorporated, Merrill Lynch, Pierce, Fenner & Smith Incorporated, and Salomon
  Smith Barney Inc., acting as representatives of the several underwriters of the Offering. Attached as
  Exhibit 5.1
  , and incorporated herein by this reference, is the opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation
  relating to the legality of the shares of common stock to be offered by the Registrant in the Offering. Attached as
  Exhibit 99.1
  , and incorporated herein by this reference, are the sections of the Prospectus Supplement dated October 24, 2002,
  to the Registration Statement on Form S-3 (File No. 333-76532) entitled "Risk Factors," "Business," and "Management."
  ITEM 7:    FINANCIAL STATEMENTS AND EXHIBITS.
  (a)
  Financial Statements of Business Acquired
  .
  Not applicable.
  (b)
  Pro Forma Financial Information
  .
  Not applicable.
  (c)
  Exhibits.
  The following exhibits are filed herewith:
  1.1
  Underwriting Agreement dated as of October 24, 2002, by and among the Registrant and Morgan Stanley & Co. Incorporated, Merrill Lynch, Pierce, Fenner
  & Smith Incorporated, and Salomon Smith Barney Inc., acting as representatives of the several underwriters named in Schedule I thereto.
  5.1
  Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation.
  23.1
  Consent of Wilson Sonsini Goodrich & Rosati, Professional Corporation (included in Exhibit 5.1).
  99.1
  Selected portions of the Registrant's Prospectus Supplement dated October 24, 2002, to the Registration Statement on Form S-3 (File No.
  333-76532).
  SIGNATURES
  Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
  authorized.
  Date:  October 28, 2002
  NPS PHARMACEUTICALS, INC.
  By:
  /s/    James U. Jensen
  James U. Jensen
  Vice President, General Counsel and Secretary
  EXHIBIT INDEX
  Exhibit Number
  Description
  1.1
  Underwriting Agreement dated as of October 24, 2002, by and among the Registrant and Morgan Stanley & Co. Incorporated, Merrill Lynch, Pierce, Fenner
  & Smith Incorporated, and Salomon Smith Barney Inc., acting as representatives of the several underwriters named in Schedule I thereto.
  5.1
  Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation.
  23.1
  Consent of Wilson Sonsini Goodrich & Rosati, Professional Corporation (included in Exhibit 5.1).
  99.1
  Selected portions of the Registrant's Prospectus Supplement dated October 24, 2002, to the Registration Statement on Form S-3 (File No.
  333-76532).